Fig. 5

KaplanāMeier estimates of overall survival (a) and leukemia transformation rate (b) based on integrated IPSS-R and mutational analyses in the 328 WHO-defined MDS patients
KaplanāMeier estimates of overall survival (a) and leukemia transformation rate (b) based on integrated IPSS-R and mutational analyses in the 328 WHO-defined MDS patients